Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (RO1- DK117396)
- License Information
-
More Information
Article History
Received: 29 November 2024
Revised: 24 February 2025
Accepted: 18 March 2025
First Online: 26 March 2025
Declarations
:
: Patent: Targeting liver nuclear receptor as a treatment for WD; inventor: James P. Hamilton (PCT/US2015/054135 filed 10/7/2015). The author declares that they have no other competing interests.
